07.01.2013 Views

Corporate Technology - Rolf Hellinger

Corporate Technology - Rolf Hellinger

Corporate Technology - Rolf Hellinger

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Research Partnerships<br />

Beth Israel Deaconess Medical Center in<br />

Boston: Detecting Cancer Cells with Light<br />

When breast cancer is detected, the first thing the doctor wants to know is<br />

whether it has spread to nearby lymph nodes. Unfortunately, the only way of<br />

determining this is to remove all potentially-affected nodes, and there are<br />

typically 30 of them in a woman’s armpit. With a view to minimizing surgical<br />

intervention, John V. Frangioni, M.D. PhD of Boston’s Beth Israel Deaconess<br />

Medical Center has developed a new imaging system that allows doctors to<br />

see exactly which lymph nodes a tumor drains into. Whether cancer cells have<br />

actually migrated to these nodes can be determined after the nodes have<br />

been removed. Known as Fluorescence-Assisted Resection and Exploration<br />

(FLARE), the system uses unique medical image fusion and visualization<br />

software developed by Siemens <strong>Corporate</strong> Research (SCR) that combines a<br />

visible light image of the area of interest with an image of the invisible<br />

infrared light reflected from a fluorescent substance. Injected into the area<br />

surrounding the tumor, the substance rapidly finds its way from the tumor to<br />

the nodes it drains into. The resulting hybrid image, which appears in real<br />

time on a color monitor, displays concentrations of brightness at the tumor<br />

and at its associated nodes, as well as a river of light beneath the skin<br />

indicating the fluid’s drainage path. And that’s just for starters. Optical<br />

systems could detect a spectrum of physiological processes indicative of<br />

cancer, such as changes in oxygen saturation and hemoglobin and water<br />

concentrations in tissues long before any anatomical or structural changes are<br />

visible to a surgeon’s eye. Such a tool could have far-reaching consequences .<br />

By providing feedback within hours regarding a tumor’s response to a new<br />

medication, in vivo optical imaging could inexpensively accelerate and<br />

personalize drug testing as well as patient treatment for shallow lesions as<br />

well as those that could be approached with future endoscopic devices. With<br />

this in mind, SCR researchers are working with the Beckman Laser Institute at<br />

the University of California in Irvine, to develop a novel software imaging<br />

platform for a hand-held laser and broadband diffuse optical spectroscopy<br />

probe that would work in much the same way as does an ultrasound<br />

transducer — but with light instead of sound. The device could be applied<br />

directly to the surface of the breast, where it will emit light at a range of<br />

wavelengths, enabling quantification of many physiological properties.<br />

44 <strong>Corporate</strong> <strong>Technology</strong><br />

Research in Moscow, St. Petersburg, Novosibirsk,<br />

and Tomsk: Strength through Cooperation<br />

Since its founding in 2005, CT Russia has accomplished a great deal (see p.<br />

28) — and much of this success is due to the approximately 20 research<br />

partnerships it has with leading Russian research institutes, universities,<br />

and industrial companies. CT researchers are now working on new types of<br />

combustion concepts for integrated gasification combustion cycle (IGCC)<br />

processes in cooperation with experts from the Moscow Engineering and<br />

Physics Institute, who have developed an experimental gas burner for the<br />

Siemens researchers to use in extensive tests of the new concept.<br />

CT is also working together with the Institute of Strength Physics and<br />

Materials Sciences (ISPMS) in Tomsk, Siberia, on the development of<br />

nanostructured ceramics for use in gas turbines. These new ceramic<br />

coatings are more ductile and longer-lasting than their current counterparts,<br />

which means that the service life of the turbines they’re installed in<br />

can be extended and the turbines themselves can be exposed to higher<br />

stresses without damage. All of this results in savings for power plant<br />

operators. ISPMS is using its expertise and tools to develop the nanostructured<br />

ceramics, and Siemens researchers are investigating how to optimally<br />

install the material in a gas turbine.<br />

Technicians need to react quickly if a complex system like a gas turbine<br />

develops a fault, as shutdowns can be very expensive. Russian researchers<br />

at Siemens are thus working with the renowned State Polytechnical<br />

University in St. Petersburg to develop intelligent software solutions that<br />

recognize and report potential defects before they occur. Such solutions<br />

monitor the operation of the system in question on the basis of<br />

programmed parameters such as oscillation and environmental data.<br />

Siemens is responsible for the software expertise here, while the university<br />

conducts practical tests, handles implementation, and optimizes the<br />

analysis system. A very different type of optimization was developed by<br />

CT researchers in conjunction with Russian oil company Rosneft. Together,<br />

they developed a chemical process to raise the pressure of less active oil<br />

deposits and thus enable the corresponding oil fields to be returned to<br />

production. CT carried out the modeling and simulations for this project,<br />

while Rosneft was responsible for the experimental part.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!